Radiopharmacology

From Wikipedia, the free encyclopedia

(Redirected from Radiopharmaceuticals)
Jump to: navigation, search

Radiopharmacology is the study and preparation of radiopharmaceuticals, which are radioactive pharmaceuticals. Radiopharmaceuticals are used in the field of nuclear medicine as tracers in the diagnosis and treatment of many diseases. Many radiopharmaceuticals use technetium (Tc-99m). In the book Technetium by Klaus Schwochau, 31 different radiopharmaceuticals based on Tc-99m are listed for imaging and functional studies of the brain, myocardium, thyroid, lungs, liver, gallbladder, kidneys, skeleton, blood and tumors.

A list of nuclear medicine radiopharmaceuticals follows. Some radioisotopes are used in ionic or inert form without attachment to a pharmaceutical, these are also included. There is a section for each radioisotope with a table of radiopharmaceuticals using that radioisotope. The sections are ordered alphabetically by the English name of the radioisotope. Sections for the same element are then ordered by atomic mass number.

Contents

47Ca is a beta and gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Ca-47-Ca2+ Bone metabolism IV In-vitro Non-imaging

11C is a positron emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
C11-L-methyl-methionine Brain tumour imaging

Parathyroid imaging

IV In-vivo Imaging

14C is a beta emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
C14-Glycocholic acid Breath test for small intestine bacterial overgrowth Oral In-vitro Non-imaging
C14-PABA (para-amino benzoic acid) Pancreatic studies Oral In-vitro Non-imaging
C14-Urea Breath test to detect Helicobacter pylori Oral In-vitro Non-imaging
C14-d-xylose Breath test for small intestine bacterial overgrowth Oral In-vitro Non-imaging

51Cr is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Cr51-Red blood cells Red cell volume; sites of sequestration; gastrointestinal blood loss IV In-vitro Non-imaging
Cr51-Cr3+ Gastrointestinal protein loss IV In-vitro Non-imaging
Cr51-EDTA (ethylenediaminetetraacetic acid) Glomerular filtration rate measurement IV In-vitro Non-imaging

57Co is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Co57-Cyanocobalamin (vitamin B12) Gastrointestinal absorption Oral In-vitro Non-imaging

58Co is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Co58-Cyanocobalamin (vitamin B12) Gastrointestinal absorption Oral In-vitro Non-imaging

169Er is a beta emitter.

Name Treatment of Route of administration
Er169-Colloid Arthritic conditions Intra-articular

18F is a positron emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
F18-FDG (Fluorodeoxyglucose) Tumour imaging

Myocardial imaging

IV In-vivo Imaging
F18-Fluoride Bone imaging IV In-vivo Imaging

67Ga is a gamma emitter. See Gallium scan.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Ga67-Ga3+ Tumour imaging IV In-vivo Imaging
Ga67-Ga3+ Infection/inflammation imaging IV In-vivo Imaging

3H or tritium is a beta emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
H3-water Total body water Oral or IV In-vitro Non-imaging

111In is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
In111-DTPA (diethylenetriaminepenta-acetic acid) GI transit Oral In-vivo Imaging
In111-DTPA (diethylenetriaminepenta-acetic acid) Cisternography Intra-cisternal In-vivo Imaging
In111-Leucocytes Infection/inflammation imaging IV In-vivo Imaging
In111-Platelets Thrombus imaging IV In-vivo Imaging
In111-Pentetreotide Somatostatin receptor imaging IV In-vivo Imaging

123I is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
I123-Iodide Thyroid uptake Oral or IV In-vivo Non-imaging
I123-Iodide Thyroid imaging

Thyroid metastases imaging

Oral or IV In-vivo Imaging
I123-o-Iodohippurate Renal imaging IV In-vivo Imaging
I123-MIBG (m-iodobenzylguanidine) Neuroectodermal tumour imaging IV In-vivo Imaging
I123-FP-CIT SPECT imaging of Parkinson's Disease IV In-vivo Imaging

131I is a beta and gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
I131-Iodide Thyroid uptake Oral In-vivo Non-imaging
I131-Iodide Thyroid metastases imaging Oral or IV In-vivo Imaging
I131-MIBG (m-iodobenzylguanidine) Neuroectodermal tumour imaging IV In-vivo Imaging

Name Treatment of Route of administration
I131-Iodide Thyrotoxicosis IV or Oral
I131-Iodide Non-toxic goitre IV or Oral
I131-Iodide Thyroid carcinoma IV or Oral
I131-MIBG (m-iodobenzylguanidine) Malignant disease IV

59Fe is a beta and gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Fe59-Fe2+ or Fe3+ Iron metabolism IV In-vitro Non-imaging

81Krm is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Kr81m-Gas Lung ventilation imaging Inhalation In-vivo Imaging
Kr-81m-Aqueous solution Lung perfusion imaging IV In-vivo Imaging

13N is a positron emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
N13-Ammonia Myocardial blood flow imaging IV In-vivo Imaging

15O is a positron emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
O15-Water Cerebral blood flow imaging

Myocardial blood flow imaging

IV bolus In-vivo Imaging

32P is a beta emitter.

Name Treatment of Route of administration
P32-Phosphate Polycythemia and related disorders IV or Oral

153Sm is a beta and gamma emitter.

Name Treatment of Route of administration
Sm153-EDTMP (Ethylenediaminotetramethylenephosphoric acid) Bone metastases IV

75Se is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Se75-Selenorcholesterol Adrenal gland imaging IV In-vivo Imaging
Se75-SeHCAT (23-Seleno-25-homo-tauro-cholate) Bile salt absorption Oral In-vivo Imaging

22Na is a positron and gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Na22-Na+ Electrolyte studies Oral or IV In-vitro Non-imaging

24Na is a beta and gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Na24-Na+ Electrolyte studies Oral or IV In-vitro Non-imaging

89Sr is a beta emitter.

Name Treatment of Route of administration
Sr89-Chloride Bone metastases IV

99mTc is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Tc99m-pertechnetate Thyroid uptake and thyroid imaging

Stomach and salivary gland imaging
Meckel's diverticulum imaging
Brain imaging
Micturating cystogram
First pass blood flow imaging
First pass peripheral vascular imaging

IV In-vivo Imaging
Tc99m-pertechnetate Lacrimal imaging Eye drops In-vivo Imaging
Tc99m-Human albumin Cardiac blood pool imaging IV In-vivo Imaging
Tc99m-Human albumin Peripheral vascular imaging IV In-vivo Imaging
Tc99m-Human albumin macroaggregates or microspheres Lung perfusion imaging IV In-vivo Imaging
Tc99m-Human albumin macroaggregates or microspheres Lung perfusion imaging with venography IV In-vivo Imaging
Tc99m-Phosphonates and phosphates Bone imaging IV In-vivo Imaging
Tc99m-Phosphonates and phosphates Myocardial imaging IV In-vivo Imaging
Tc99m-DTPA (diethylenetriaminepenta-acetic acid) Renal imaging
First pass blood flow studies
Brain imaging
IV In-vivo Imaging
Tc99m-DTPA (diethylenetriaminepenta-acetic acid) Lung ventilation imaging Aerosol inhalation In-vivo Imaging
Tc99m-DMSA(V) (dimercaptosuccinic acid) Tumour imaging IV In-vivo Imaging
Tc99m-DMSA(III) (dimercaptosuccinic acid) Renal imaging IV In-vivo Imaging
Tc99m-Colloid Bone marrow imaging

GI Bleeding

IV In-vivo Imaging
Tc99m-Colloid Lymph node imaging Interstitial In-vivo Imaging
Tc99m-Colloid Oesophageal transit and reflux imaging Oral In-vivo Imaging
Tc99m-Colloid Lacrimal imaging Eye drops In-vivo Imaging
Tc99m-HIDA (Hepatic iminodiacetic acid) Functional biliary system imaging IV In-vivo Imaging
Tc99m-Denatured red bood cells Red cell volume IV In-vitro Non-imaging
Tc99m-Red blood cells GI bleeding

Cardiac blood pool imaging
Peripheral vascular imaging

IV In-vivo Imaging
Tc99m-MAG3 (mercaptoacetyltriglycine) Renal imaging

First pass blood flow imaging

IV In-vivo Imaging
Tc99m-HMPAO (Hexamethyl-propylene amine oxime) Cerebral blood flow imaging IV In-vivo Imaging
Tc99m-HMPAO (Hexamethyl-propylene amine oxime) labelled leucocytes Infection/inflammation imaging IV In-vivo Imaging
Tc99m-Sestamibi Parathyroid imaging

Non-specific tumour imaging
Thyroid tumour imaging
Breast imaging
Myocardial imaging

IV In-vivo Imaging
Tc99m-Sulesomab (IMMU-MN3 murine Fab'-SH antigranulocyte monoclonal antibody fragments) Infection/inflammation imaging IV In-vivo Imaging
Tc99m-Technegas Lung ventilation imaging Inhalation In-vivo Imaging
Tc99m-Human immunoglobulin Infection/inflammation imaging IV In-vivo Imaging
Tc99m-Tetrofosmin Parathyroid imaging

Myocardial imaging

IV In-vivo Imaging
Tc99m-ECD (ethyl cysteinate dimer) Brain imaging IV In-vivo Imaging

201Tl is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Tl201-Tl+ Non-specific tumour imaging

Thyroid tumour imaging
Myocardial imaging
Parathyroid imaging

IV In-vivo Imaging

133Xe is a gamma emitter.

Name Investigation Route of administration In-vitro / in-vivo Imaging / non-imaging
Xe133-gas Lung ventilation studies Inhalation In-vivo Imaging
Xe133 in isotonic sodium chloride solution Cerebral blood flow IV In-vivo Imaging

90Y is a beta emitter.

Name Treatment of Route of administration
Y90-Silicate Arthritic conditions Intra-articular
Y90-Silicate Malignant disease Intracavitary

  • Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of radioactive substances advisory committee. December 1998. Produced by the National Radiological Protection Board.
  • Malabsorption. In: The Merck Manual of Geriatrics, chapter 111.
  • Leukoscan summary of product characteristics (Tc99m-Sulesomab).
  • Schwochau, Klaus. Technetium. Wiley-VCH (2000). ISBN 3-527-29496-1
Advanced Search
Included Web Search Engines


Safe Search

close

Top Matching Results

Occasionally Search.com will highlight specialized results that are based on the context of your query. Examples of specialized results include specific links to news, images, or video.

Top Matching Results may highlight information from other Search.com pages, content from the CNET Network of sites, or third party content. The listings are based purely on relevance. Search.com does not receive payment for listings in this section but our partners that provide this data may get paid for listing these products.

Sponsored Links

This section contains paid listings which have been purchased by companies that want to have their sites appear for specific search terms and related content. These listings are administered, sorted and maintained by a third party and are not endorsed by Search.com.

Search Results

Search.com sends your search query to several search engines at one time and integrates the results into one list which has been sorted by relevance using Search.com's proprietary algorithm. You can customize the list of search engines included in your metasearch from the preferences.

The search engines that are used in your metasearch may allow companies to pay to have their Web sites included within the results. To view the Paid Inclusion policy for a specific search engine, please visit their Web site. Search.com does not accept payment or share revenue with any search engine partner for listings in this section.